Related Experiment Video

Updated: May 11, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein

Yunzi Chen1, Jing Zhang, Xin Ge

  • 1Laboratory of Metabolic Disease Research and Drug Development, China Medical University, Shenyang 110000, China.

The Journal of Biological Chemistry
|May 15, 2013
PubMed

Insights

1,25-Dihydroxyvitamin D (1,25(OH)2D3) suppresses NF-κB activation by binding to the vitamin D receptor (VDR). This VDR-IKKβ interaction blocks NF-κB pathway signaling, offering new therapeutic insights.

Area of Science:

  • Molecular Biology
  • Immunology
  • Endocrinology

Background:

  • 1,25-Dihydroxyvitamin D (1,25(OH)2D3) is known to inhibit NF-κB signaling.
  • The precise molecular mechanisms underlying this suppression are not fully elucidated.

Purpose of the Study:

  • To investigate the molecular mechanism by which 1,25(OH)2D3 suppresses NF-κB activation.
  • To identify the specific protein interactions involved in this pathway.

Main Methods:

  • Co-immunoprecipitation and GST pull-down assays to confirm protein interactions.
  • Cell-based assays using VDR(-/-) cells and VDR C-terminus reconstitution.
  • Western blotting to assess protein phosphorylation and nuclear translocation.

Main Results:

  • Demonstrated a physical interaction between the vitamin D receptor (VDR) and IκB kinase β (IKKβ).
  • Showed that 1,25(OH)2D3 enhances the VDR-IKKβ interaction, inhibiting TNFα-induced NF-κB activation.
  • Identified that VDR C-terminus binding to IKKβ disrupts IKK complex formation and IκBα phosphorylation.

Conclusions:

  • Defined a novel mechanism where 1,25(OH)2D3-VDR interaction inhibits NF-κB activation by preventing IKK complex assembly.
  • This interaction blocks p65/p50 nuclear translocation, thereby suppressing inflammatory gene expression.
  • Highlights a new VDR-mediated regulatory pathway for NF-κB signaling.
Keywords:
IKKβInflammationNF-κBNuclear ReceptorsProtein-Protein InteractionsVitamin D

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF311:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...